Bevacizumab in a growing teratoma syndrome. Case report [5]

Annals of Oncology

Volumn 18, Issue 5, 2007, Pages 962-963

  Mego, Miso ^a   Reckova M ^a   Sycova Mila Z ^a   Obertova, J ^a   Brozmanova, K ^a   Salek, T ^a   Mardiak, J ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ABDOMINAL MASS; ADULT; BACKACHE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; HISTOPATHOLOGY; HUMAN; LETTER; LYMPH NODE METASTASIS; MALE; ORCHIECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCROTAL SWELLING; TERATOCARCINOMA; TERATOMA; TUMOR GROWTH; TUMOR VOLUME;

ADULT; ANTIBODIES, MONOCLONAL; DISEASE PROGRESSION; HUMANS; LYMPHATIC DISEASES; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; TERATOMA; TESTICULAR NEOPLASMS;

EID: 34447338085     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm125     Document Type: Letter

References (5)

1. Andre F, Fizazi K, Culine S et al. The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients. Eur J Cancer 2000; 36: 1389-1394.
2. Rustin GJ, Kaye SB, Williams CJ et al. Response of differentiated but not anaplastic teratoma to interferon. Br J Cancer 1984, 50: 611-616.
3. Adam M, Schmidt D, Wardelmann E et al. Angiogenetic protooncogene ets-1 induced neovascularization is involved in the metastatic process of testicular germ cell tumors. Eur Urol 2003; 44: 329-336.
4. Fukuda S, Shirahama T, Imazono Y et al. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease. Cancer 1999; 85: 1323-1330.
5. Jones A, Fujiyama C, Turner K et al. Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testis. BJU Int 2000; 86: 80-86.